SCHEMBL9822185

SCHEMBL9822185

CC(O)c1nc2ncc(C(=O)O)c(S)n2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.43
POLB P06746 1/20 0.39
ALDH1A1 P00352 4/20 0.36
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.33
ADORA3 P0DMS8 1/20 0.32
ADORA2A P29274 1/20 0.32
ADORA1 P30542 1/20 0.32
NPC1 O15118 2/20 0.32
RAB9A P51151 2/20 0.32
HPGD P15428 2/20 0.32
MAPT P10636 1/20 0.31
GABRP O00591 1/20 0.30
GABRD O14764 1/20 0.30
GABRA1 P14867 1/20 0.30
GABRB1 P18505 1/20 0.30
GABRG2 P18507 1/20 0.30
GABRB3 P28472 1/20 0.30
GABRA5 P31644 1/20 0.30
GABRA3 P34903 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10415953 0.84 KDM4E (0.42) KDM4EPOLBALDH1A1KMT2ATDP1
SCHEMBL10407785 0.80 POLB (0.59) KDM4EPOLBALDH1A1KMT2ATDP1
SCHEMBL9677476 0.77 KDM4E (0.44) KDM4EPOLBALDH1A1KMT2ATDP1
SCHEMBL9822031 0.75 KDM4E (0.41) KDM4EPOLBALDH1A1KMT2ATDP1
SCHEMBL9822273 0.74 KDM4E (0.42) KDM4EPOLBALDH1A1KMT2ATDP1
SCHEMBL10407369 0.72 ALDH1A1 (0.60) KDM4EPOLBALDH1A1KMT2ATDP1
SCHEMBL9822217 0.71 KDM4E (0.40) KDM4EPOLBALDH1A1KMT2ATDP1
SCHEMBL9822214 0.70 SORD (0.35)
SCHEMBL10407079 0.69 CSNK1D (0.44) KDM4EPOLBALDH1A1KMT2ATDP1
SCHEMBL9679451 0.69 KDM4E (0.37) KDM4EPOLBALDH1A1TDP1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4987129-A BACTERICIDES SANKEI PHARMACEUTICAL CO., LTD. (JP) 1991-01-22 US disclosed
US-4958019-A Intermediates for synthesis of cephalosporin compounds SANKEI PHARMACEUTICAL CO., LTD. (JP) 1990-09-18 US disclosed
US-4956462-A Bactericides, ANTIBIOTICS, CEPHALOSPORINS SANKEI PHARMACEUTICAL CO., LTD. (JP) 1990-09-11 US disclosed
US-4812501-A AGAINST OXIDATIVE, THERMAL AND ACTINIC DEGRADATION CIBA-GEIGY CORPORATION (US) 1989-03-14 US disclosed
EP-0302633-A2 Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same SANKEI PHARMACEUTICAL COMPANY LIMITED (JP) 1989-02-08 EP disclosed
US-4751319-A 1,3,2-oxazaphospholdine stabilizers CIBA-GEIGY CORPORATION (US) 1988-06-14 US disclosed